NWTS - 5 was a multi-institutional clinical trial for patients less than 16 years of age at diagnosis with specific renal neoplasms who were diagnosed between August 1, 1995 and May 31, 2002. A ...
The prognosis of patients with early relapsed or refractory large B-cell lymphoma after the receipt of first-line chemoimmunotherapy is poor. In this international, phase 3 trial, we randomly assigned ...
Relapse, or recurrence, occurs when multiple myeloma symptoms return, such as bone pain, fatigue, and kidney problems. It’s possible to live for many years after a relapse of multiple myeloma. Outlook ...
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report This ...
As with many types of cancer, acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, can come back after successful treatment. This is known as a relapse. Relapses can cause you ...
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia (ALL), the most common cancer in children, to inform more effective treatment strategies and detect disease ...
– Trial met its primary endpoint with a CR/CRh rate of 23% at interim analysis of the pooled KMT2Ar AML and ALL cohorts (p-value = 0.0036); an additional 14% of patients proceeded to transplant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results